Monday, October 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

Fiserv Rolls Out 24/7 USD Settlement Tool to Challenge Stablecoins

SiterGedge by SiterGedge
February 13, 2026
in Banking & Insurance, Blockchain, Crypto Stocks, Tech & Software
0
Fiserv Stock
0
SHARES
44
VIEWS
Share on FacebookShare on Twitter

Fiserv has unveiled a new platform, INDX, aimed at letting institutional crypto players settle US dollars around the clock while sidestepping the regulatory risks tied to digital tokens. Debuted on February 12, the solution targets a core mismatch: blockchain settlements operate continuously, whereas traditional banking functions within standard business hours. INDX is designed to fill that gap.

Key specifications
– Real-time USD settlement, 365 days a year
– FDIC insurance up to $25 million per account (twenty times the standard limit)
– Connectivity to more than 1,100 US banking institutions via the Fiserv Deposit Network

Off-chain, but blockchain-fast
The centerpiece is that funds stay off-chain within a regulated banking system yet move with the speed typical of blockchain settlements. By doing so, INDX presents itself as a compliant alternative to popular stablecoins such as USDC or Tether, eliminating smart-contract exposure and concerns around collateralization.

The platform also aligns with CEO Mike Lyons’ “One Fiserv” initiative, which seeks to knit the company’s fragmented technologies together to unlock synergies across the organization.

Should investors sell immediately? Or is it worth buying Fiserv?

Recent earnings context
The INDX unveiling followed the company’s Q4 earnings release on February 10, which offered several positives after a challenging year. Highlights include:

  • Adjusted Q4 EPS: $1.99 (consensus $1.90–$1.92)
  • Q4 revenue: about $4.90 billion (essentially flat versus the prior year)
  • 2026 guidance: EPS $8.00–$8.30, organic revenue growth of 1–3%

The stock moved higher briefly after the results, with investors rewarding the improved profitability even as the revenue outlook remained cautious.

Analyst sentiment
On February 11, Stephens trimmed its target price to $70, signaling persistent caution. JPMorgan and other houses have also adjusted targets in recent days. The prevailing view among analysts is that valuations look modest relative to the growth outlook, and that organic growth remains a challenge.

What to watch next
The big questions now are whether INDX can generate meaningful volumes and whether the second-half 2026 execution of the One Fiserv reorganization will deliver genuine growth momentum. Market adoption of the new settlement framework for digital assets could serve as a catalyst, assuming institutional clients pivot away from stablecoins toward this regulated, faster, off-chain solution.

Ad

Fiserv Stock: Buy or Sell?! New Fiserv Analysis from October 5 delivers the answer:

The latest Fiserv figures speak for themselves: Urgent action needed for Fiserv investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 5.

Fiserv: Buy or sell? Read more here...

Tags: Fiserv
SiterGedge

SiterGedge

Related Posts

Commerzbank Stock
Banking & Insurance

Commerzbank’s CEO Puts a Price on Her Future as UniCredit Circles Closer

September 7, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Next Post
Coinbase Stock

Coinbase Slips into Loss After Eight Quarters of Profit

Apex Critical Metals Stock

Apex Critical Metals accelerates Rift drilling with a second rig in Nebraska

Cyclacel Pharmaceuticals Stock

From Biotech to Fire-Protection: Bio Green Med’s Strategic Pivot

Recommended

Alternative Energy Stock Market Today (1)

Title Short Interest in Ovintiv Surges by 821 as of March 6 2024

3 years ago
United Parcel Service Stock

UPS Faces Critical Test as Q3 Earnings Approach

12 months ago
Nuscale Power Stock

NuScale Power Shares Slide Ahead of Earnings Release

12 months ago
Xylem Stock

Xylem Shares Surge Following Exceptional Quarterly Performance

11 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

From GPUs to Guardrails: Q4’s Security Rotation Begins

The Rate Plateau’s Real Winners Aren’t Chipmakers

The K-Shaped Economy Meets a 19-Year High in Yields

Consumer Strength Meets Bond Market Stress Ahead of Q4

Borrowed Bull: Record Margin Debt Meets a Record Foreign Inflow

Software Over Silicon: Microsoft’s Bet to Monetize the AI Boom

Trending

Oracle Stock
Newsletter

Cash Flow Beats Backlog as Banks Brace for Earnings

by Stephanie Dugan
October 5, 2026
0

Dear readers, Investors have a simple test for the fourth quarter: show me the cash. Microsoft passes...

AMD Stock

Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t

October 3, 2026
Nike Stock

Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

October 2, 2026
Alphabet Stock

From GPUs to Guardrails: Q4’s Security Rotation Begins

October 1, 2026
Charles Schwab Stock

The Rate Plateau’s Real Winners Aren’t Chipmakers

September 30, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cash Flow Beats Backlog as Banks Brace for Earnings
  • Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t
  • Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com